First Look Analyst Calls Briefing for Tuesday, November 8, 2022
Here are the early analyst research calls for Tuesday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Block (SQ) upgraded to Outperform from Neutral at Macquarie; tgt $100
> Dave & Buster’s (PLAY) upgraded to Buy from Hold at Deutsche Bank; tgt $48
> Energy Recovery (ERII) upgraded to Outperform from Mkt Perform at Raymond James; tgt $23
> Global Partners (GLP) upgraded to Buy from Hold at Stifel; tgt raised to $35
> Mettler-Toledo (MTD) upgraded to Neutral from Sell at Goldman; tgt raised to $1355
> Scotts Miracle-Gro (SMG) upgraded to Overweight from Equal Weight at Barclays; tgt $75
> Southern Copper (SCCO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $54
> Telephone & Data (TDS) upgraded to Neutral from Underweight at JP Morgan; tgt lowered to $14
> US Cellular (USM) upgraded to Neutral from Underweight at JP Morgan; tgt lowered to $24
Downgrades:
> Arcosa (ACA) downgraded to Equal-Weight from Overweight at Stephens; tgt lowered to $65
> AVEO Oncology (AVEO) downgraded to Hold from Buy at Stifel; tgt $15
> Benefitfocus (BNFT) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> ICU Medical (ICUI) downgraded to Mkt Perform from Outperform at Raymond James
> Jack In The Box (JACK) downgraded to Hold from Buy at Deutsche Bank; tgt $88
> Lyft (LYFT) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $18
> Marsh McLennan (MMC) downgraded to Neutral from Overweight at Atlantic Equities; tgt $185
> National Storage Affiliates (NSA) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $42
Others:
> ASML (ASML) initiated with an Overweight at Morgan Stanley
> Eni S.p.A. (E) resumed with an Outperform at Exane BNP Paribas
> Generation Bio (GBIO) initiated with a Buy at Canaccord Genuity; tgt $9
> National Grid (NGG) resumed with an Overweight at JP Morgan
> Rocket Pharmaceuticals (RCKT) initiated with a Buy at Canaccord Genuity; tgt $53
> STMicroelectronics (STM) initiated with an Equal-Weight at Morgan Stanley
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.